Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis

[1]  C. Husten,et al.  Cigarette Smoking Among Adults, United States , 2006 .

[2]  R. Gillum,et al.  Frequency of attendance at religious services and cigarette smoking in American women and men: the Third National Health and Nutrition Examination Survey. , 2005, Preventive Medicine.

[3]  U. Ackermann-Liebrich,et al.  Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study , 2005, Respiratory research.

[4]  D. Jarvis,et al.  Smoking cessation, lung function, and weight gain: a follow-up study , 2005, The Lancet.

[5]  Iñaki Galán-Labaca,et al.  Smoking attributable mortality in the community of Madrid: 1992-1998. , 2005, European journal of public health.

[6]  D. Sin,et al.  The interactions between cigarette smoking and reduced lung function on systemic inflammation. , 2005, Chest.

[7]  A. James,et al.  Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. , 2005, American journal of respiratory and critical care medicine.

[8]  R. Pauwels,et al.  Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.

[9]  N. Day,et al.  Childhood smoking is an independent risk factor for obstructive airways disease in women , 2004, Thorax.

[10]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[11]  M. Wysocki,et al.  Changes in lung function determined longitudinally compared with decline assessed cross-sectionally. The Cracow study , 1986, European Journal of Epidemiology.

[12]  J. Heinrich,et al.  Association of hormone replacement therapy with bronchial hyper-responsiveness. , 2003, Respiratory medicine.

[13]  W. Bailey,et al.  Changes in smoking status affect women more than men: results of the Lung Health Study. , 2003, American journal of epidemiology.

[14]  D. Sin,et al.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. , 2003, Circulation.

[15]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[16]  P. Enright,et al.  An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern italy. , 2001, Chest.

[17]  C. Murray,et al.  Burden of disease--implications for future research. , 2001, JAMA.

[18]  J. Cauley,et al.  Hormone replacement therapy is associated with higher FEV1 in elderly women. , 2001, American journal of respiratory and critical care medicine.

[19]  J. Cauley,et al.  Hormone Replacement Therapy Is Associated with Higher FEV 1 in Elderly Women , 2001 .

[20]  P. Enright,et al.  Predictors of loss of lung function in the elderly: the Cardiovascular Health Study. , 2001, American journal of respiratory and critical care medicine.

[21]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[22]  Dirkje S Postma,et al.  Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study , 2000, The Lancet.

[23]  W. Bailey,et al.  Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease , 2000 .

[24]  G. Lowe,et al.  Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.

[25]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[26]  W. Bailey,et al.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.

[27]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[28]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[29]  J. Bousquet,et al.  Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. , 1997, American journal of respiratory and critical care medicine.

[30]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[31]  Denmark,et al.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study , 2002 .

[32]  D. Dockery,et al.  Effects of cigarette smoking on lung function in adolescent boys and girls. , 1996, The New England journal of medicine.

[33]  J. Vestbo,et al.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.

[34]  P. Enright,et al.  Rates of decline in lung function among subjects who restart cigarette smoking. , 1996, Chest.

[35]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[36]  G. Viegi,et al.  Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. , 1995, American journal of respiratory and critical care medicine.

[37]  B. Rosner,et al.  Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. , 1995, American journal of respiratory and critical care medicine.

[38]  H. Tunstall-Pedoe,et al.  Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease. , 1994, Journal of epidemiology and community health.

[39]  X. Xu,et al.  Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.

[40]  H. V. van Houwelingen,et al.  Growth of airways and air spaces in teenagers is related to sex but not to symptoms. , 1993, Journal of applied physiology.

[41]  E. Skobeloff,et al.  The influence of age and sex on asthma admissions. , 1992, JAMA.

[42]  D. Dockery,et al.  Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. , 1992, The American review of respiratory disease.

[43]  E. Bleecker,et al.  The Lung Health Study: Airway Responsiveness to Inhaled Methacholine in Smokers with Mild to Moderate Airflow Limitation , 1992 .

[44]  C. la Vecchia,et al.  The antiestrogenic effect of cigarette smoking in women. , 1990, American journal of obstetrics and gynecology.

[45]  P. Schnohr,et al.  Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. , 1990, Thorax.

[46]  V. Clark,et al.  The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. , 1984, The American review of respiratory disease.

[47]  M. Hibbert,et al.  Changes in lung, airway, and chest wall function in boys and girls between 8 and 12 yr. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[48]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.